" /> Lipodystrophy, partial, acquired, susceptibility to - CISMeF





Preferred Label : Lipodystrophy, partial, acquired, susceptibility to;

Symbol : APLD;

CISMeF acronym : APLD;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Apld, susceptibility to; Lipodystrophy, partial, progressive; Lipodystrophy, cephalothoracic type; Barraquer-simons syndrome;

Description : Acquired partial lipodystrophy is characterized clinically by the gradual onset of bilaterally symmetrical loss of subcutaneous fat from the face, neck, upper extremities, thorax, and abdomen, in the 'cephalocaudal' sequence, sparing the lower extremities (summary by Misra et al., 2004). The disorder is not inherited in a classic mendelian pattern; it rather represents a phenotype with a complex etiology. Affected individuals may have genetic susceptibility factors that require the additional presence of environmental factors or acquired disorders to be expressed (summary by Hegele et al., 2006). Most cases are sporadic, family history is negative, and females are more often affected than males (ratio, 4:1). There is an association between APLD and autoimmune diseases (Misra and Garg, 2003; Misra et al., 2004), and a subset of patients have APLD associated with low serum complement component C3 and the autoantibody C3 nephritic factor, with or without membranoproliferative glomerulonephritis (APLDC3; 613913). Acquired partial lipodystrophy is distinct from inherited forms of partial lipodystrophy, which are metabolic disorders that show clear mendelian inheritance (see, e.g., FPLD1, 608600).;

Inheritance : Autosomal dominant;

Molecular basis : Susceptibility conferred by mutation in the lamin B2 gene (LMNB2, 150341.0001);

Laboratory abnormalities : Dyslipidemia;

Prefixed ID : #608709;

Details


You can consult :


Nous contacter.
30/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.